About This Study
The purpose of this study is to learn more about a new medicine called CLN-619. We want to see if the medicine is safe and useful in treating patients with multiple myeloma that has come back or has not responded to other treatment. The medicine is given through an IV every three weeks. The study will also look at different doses to find the best one.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC
- Greater Winston-Salem, NC